Center-Authored Papers

Filters: Author is Sargent, Daniel  [Clear All Filters]
G
de Gramont A, Hubbard J, Shi Q, O'Connell MJ, Buyse M, Benedetti JK, Bot B, O'Callaghan C, Yothers G, Goldberg RM et al..  2010.  Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(3):460-5. Abstract
O
Oba K, Paoletti X, Alberts S, Bang Y-J, Benedetti J, Bleiberg H, Catalano P, Lordick F, Michiels S, Morita S et al..  2013.  Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.. Journal of the National Cancer Institute. 105(21):1600-7. Abstract
P
Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon J-P, Rougier P, Sakamoto J, Sargent D, Sasako M et al..  2010.  Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.. JAMA : the journal of the American Medical Association. 303(17):1729-37. Abstract
S
Schroen AT, Petroni GR, Wang H, Thielen MJ, Sargent D, Benedetti JK, Cronin WM, Wickerham DL, Wang XF, Gray R et al..  2011.  Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.. Clinical trials (London, England). 8(5):591-600. Abstract
Seymour L, Ivy PS, Sargent D, Spriggs D, Baker L, Rubinstein L, Ratain MJ, LeBlanc M, Stewart D, Crowley J et al..  2010.  The design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committee.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(6):1764-9. Abstract